Français
ItalianoBond Viatris 4% ( US92556VAF31 ) in USD
| Issuer | Viatris | ||||||
| Market price |  67.56 % ⇌ |
||||||
| Country |  United States
|
||||||
| ISIN code |
 US92556VAF31 ( in USD )
|
||||||
| Interest rate | 4% per year ( payment 2 times a year) | ||||||
| Maturity | 21/06/2050 | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | / | ||||||
| Total amount | / | ||||||
| Cusip | 92556VAF3 | ||||||
| Standard & Poor's ( S&P ) rating | BB+ ( Non-investment grade speculative ) | ||||||
| Moody's rating | Baa3 ( Lower medium grade - Investment-grade ) | ||||||
| Next Coupon | 22/12/2026 ( In 93 days ) | ||||||
| Detailed description |
Global healthcare company formed from the merger of Mylan and Upjohn. The Bond issued by Viatris ( United States ) , in USD, with the ISIN code US92556VAF31, pays a coupon of 4% per year. The coupons are paid 2 times per year and the Bond maturity is 21/06/2050 The Bond issued by Viatris ( United States ) , in USD, with the ISIN code US92556VAF31, was rated Baa3 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Viatris ( United States ) , in USD, with the ISIN code US92556VAF31, was rated BB+ ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||